Literature DB >> 32009180

Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.

George Z Rassidakis1,2, Olga Stromberg3, Ioanna Xagoraris4, Kenbugul Jatta5, Kristina Sonnevi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32009180     DOI： 10.1007/s00277-020-03941-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Authors:  Hui Liu; Qi Shen; Chung-Che Chang; Shimin Hu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 2.  Histiocytic and dendritic cell neoplasms of the mediastinum.

Authors:  Ezra Baraban; Kumarasen Cooper
Journal:  Mediastinum       Date:  2020-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.